Methods and composition for a binding molecule targeting cancer cells expressing SSX2 peptide 41-49 in HLA-A*0201 context

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 12227590
APP PUB NO 20220185909A1
SERIAL NO

17552862

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed are Synovial Sarcoma X breakpoint 2 binding molecules and methods for their use in the detection and treatment of cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • THE CHILDREN'S NATIONAL MEDICAL CENTER; THE GEORGE WASHINGTON UNIVERSITY; UNIVERSITAT DES SAARLANDES

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bollard, Catherine Bethesda, US 9 2
Held, Gerhard Homburg, DE 2 5
Pfreundschuh,, deseased Michael Homburg, DE 1 0
Raskin, Scott Silver Spring, US 1 0
Sturm, Christine Homburg, DE 1 0
Van, Pelt Stacey Houston, US 1 0
Yvon, Eric Bethesda, US 3 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Aug 18, 2028
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 18, 2032
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 18, 2036
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00